经桡动脉或股动脉入路后急性肾损伤与出血事件对急性冠脉综合征患者死亡率的影响:MATRIX试验二次分析
该研究为MATRIX试验的二次分析,纳入接受侵入性管理的急性冠脉综合征患者,比较桡动脉与股动脉入路对出血、急性肾损伤(AKI)及全因死亡率的影响。多状态模型显示,桡动脉入路降低死亡率主要与预防AKI相关,出血事件的独立作用证据有限。
要点
- 桡动脉入路较股动脉入路显著降低AKI后死亡风险(HR 0.55,95%CI 0.31-0.97)。
- 经冠脉介入→AKI→死亡路径的风险比在桡动脉组为0.49(95%CI 0.26-0.92)。
- 出血至死亡及介入→出血→死亡路径在两组间无显著差异。
核心结论
- 在MATRIX试验中,桡动脉入路较股动脉入路的死亡率获益主要由预防AKI所驱动。
- 出血事件对死亡率获益的独立作用证据有限。
研究设计与样本
- MATRIX试验的二次分析,纳入接受冠脉介入的急性冠脉综合征成人患者。
- 采用多状态模型和竞争风险模型分析桡动脉与股动脉入路对出血、AKI及全因死亡率的影响。
主要发现
- 桡动脉组较股动脉组从AKI到死亡的转移风险显著降低(HR 0.55,95%CI 0.31-0.97)。
- 桡动脉组从冠脉介入到AKI再到死亡的路径风险显著降低(HR 0.49,95%CI 0.26-0.92)。
- 两组间从出血到死亡的风险无显著差异(HR 1.05,95%CI 0.42-2.64)。
- 两组间从冠脉介入到出血再到死亡的路径风险无显著差异(HR 0.84,95%CI 0.28-2.49)。
临床怎么用
- 对于接受侵入性管理的急性冠脉综合征患者,优先选择桡动脉入路可能通过减少AKI来降低死亡风险。
- 出血事件的预防对死亡率获益的独立贡献可能不如AKI预防重要,但仍需综合管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: In the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX) trial, adults with acute coronary syndrome undergoing coronary intervention who were allocated to radial access had a lower risk of bleeding, acute kidney injury (AKI), and all-cause mortality, as compared with those allocated to femoral access. The mechanism of the mortality benefit of radial access remained unclear. METHODS AND RESULTS: We used multistate and competing risk models to determine the effects of radial and femoral access on bleeding, AKI and all-cause mortality in the MATRIX trial and to disentangle the relationship between these different types of events. There were large relative risk reductions in mortality for radial compared with femoral access for the transition from AKI to death [hazard ratio (HR) 0.55, 95% confidence interval (CI) 0.31-0.97] and for the pathway from coronary intervention to AKI to death (HR 0.49, 95% CI 0.26-0.92). Conversely, there was little evidence for a difference between radial and femoral groups for the transition from bleeding to death (HR 1.05, 95% CI 0.42-2.64) and the pathway from coronary intervention to bleeding to death (HR 0.84, 95% CI 0.28-2.49). CONCLUSION: The prevention of AKI appeared predominantly responsible for the mortality benefit of radial as compared with femoral access in the MATRIX trial. There was little evidence for an equally important, independent role of bleeding.
引用
- Rothenbühler M, Valgimigli M, Odutayo A, et al. Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial. Eur Heart J. 2019. PMID: 30689825. doi:10.1093/eurheartj/ehy860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。